Cargando…
KLK-targeted Therapies for Prostate Cancer
Alternative treatments are urgently needed for prostate cancer, especially to address the aggressive metastatic castration-resistant disease. Proteolytic enzymes are involved in cancer growth and progression. The prostate produces several proteases, the most abundant ones being two members of the ka...
Autores principales: | Hannu, Koistinen, Johanna, Mattsson, Ulf-Håkan, Stenman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Communications and Publications Division (CPD) of the IFCC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975297/ https://www.ncbi.nlm.nih.gov/pubmed/27683469 |
Ejemplares similares
-
KLK3/PSA and cathepsin D activate VEGF-C and VEGF-D
por: Jha, Sawan Kumar, et al.
Publicado: (2019) -
KLK3 in the Regulation of Angiogenesis—Tumorigenic or Not?
por: Koistinen, Hannu, et al.
Publicado: (2021) -
Proteolytic Activity of Prostate-Specific Antigen (PSA) towards Protein Substrates and Effect of Peptides Stimulating PSA Activity
por: Mattsson, Johanna M., et al.
Publicado: (2014) -
Genetic Association of the KLK4 Locus with Risk of Prostate Cancer
por: Lose, Felicity, et al.
Publicado: (2012) -
Biochemical activity induced by a germline variation in KLK3 (PSA) associates with cellular function and clinical outcome in prostate cancer
por: Srinivasan, Srilakshmi, et al.
Publicado: (2023)